Clinical trial Recruiting at 1 site Interventional Ages 45 to 85

How deep brain stimulation affects speech and swallowing in Parkinson disease

Official title: Effects of Deep Brain Stimulation (DBS) on Laryngeal Function and Associated Behaviors in Parkinson Disease

Run by University of Florida · NCT07026734 · Data updated 2026-11-12

This study will test whether deep brain stimulation to the subthalamic nucleus (STN) or globus pallidus interna (GPi) changes voice, speech, swallowing, and cough in people with idiopathic Parkinson disease who are approved for first-time DBS surgery.

Quick facts

Study typeInterventional
Ages45 Years to 85 Years
SexAll
Enrollment100 (estimated)
SponsorUniversity of Florida
Academic / other
Locations1 site (Gainesville, Florida)
StatusRecruiting
StartedMay 26, 2025
Main results expectedMay 2028
Study endsMay 2029
Registry record updatedJuly 21, 2026
Trial IDNCT07026734 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with idiopathic (non‑genetic) Parkinson disease, Hoehn & Yahr stage I–IV, approved for first-time DBS to STN or GPi, and who have mild or moderate voice or swallowing problems are ideal candidates.

Probably not a fit

People with other neurologic disorders, prior DBS electrodes, severe cognitive or unstable psychiatric problems, structural or non‑PD voice disorders, chronic refractory cough, recent head/neck/lung cancer, or a bleeding disorder are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will enroll people with idiopathic Parkinson disease who are approved for first-time DBS to either STN or GPi and who have mild to moderate voice or swallowing problems. Participants will undergo validated, objective measurements of voice, speech, swallowing, and cough before and after surgery and with stimulation turned ON and OFF. The study will compare outcomes by target site (STN versus GPi) and incorporate neurostimulation parameters and connectivity information where available. The work is led by the University of Florida with collaboration from the NIDCD at a single center in Gainesville, Florida.

Why it matters

Potential benefit: If successful, the findings could help clinicians choose DBS targets and counsel patients to reduce the risk of worsening voice or swallowing and improve quality of life.

How similar studies have gone: Prior reports are limited and inconclusive—most existing data come from bilateral STN DBS and do not definitively compare STN versus GPi effects on voice and swallowing.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Diagnosis of idiopathic (non-genetic/familial) PD made by fellowship-trained neurologist by applying strict UK brain bank criteria

Hoehn \& Yahr staging I - IV

Approved for DBS surgery to either STN or GPi, with NO existing DBS electrodes.

Mild or moderate voice / swallow problems

Exclusion Criteria:

Neurological disorder(s) other than PD (including essential tremor) Severe neuropsychological dysfunction, unstable psychiatric disease at the discretion of the treating neurologist/psychiatrist (i.e., severe depression) or moderate to severe cognitive impairment.

History of:

* Head, neck, or lung cancer (except minor squamous cell skin cancers)
* Structural, functional, or neurologic voice disorder unrelated to PD
* Chronic refractory cough
* Bleeding disorder

Where it's running

  • University of Florida, Norman Fixel Institute for Neurological Diseases
    Gainesville, Florida, United States
    Recruiting

Study contacts

  • Principal investigator: Karen Hegland, Ph.D. — University of Florida
  • Study coordinator: Yuhan Mou, Ph.D.
  • Email: ymou@ufl.edu
  • Phone: 352-273-6561

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.